Endogenously produced interferon α protects mice from herpes simplex virus type 1 corneal disease Free

Abstract

Intravenous (i.v.) injection of u.v. light-inactivated herpes simplex virus type 1 (UV HSV-1) at the time of HSV-1 corneal infection reduced the cytotoxic T lymphocyte (CTL) response to HSV-1, and significantly reduced the incidence of HSV-1-induced corneal stromal disease in A/J mice. The spread of HSV-1 through the eye after corneal infection, detected using engineered HSV-1 (US3::Tn5-) with the gene under the transcriptional control of the viral late gene promoter for glycoprotein C, was also markedly reduced by i.v. UV HSV-1 injection. The restriction of HSV-1 corneal invasiveness in i.v. UV HSV-1-injected mice preceded the onset of a detectable specific cell-mediated or humoral immune response to HSV-1, and was accompanied by an elevated serum titre of interferon (IFN-), reversed by anti-IFN-/ antibody, and mimicked by systemic IFN- treatment. IFN--treated mice developed a normal CTL response to HSV-1 after corneal infection, but the corneal invasiveness of the virus was markedly reduced and none of the treated mice developed corneal stromal disease. Together with our previous findings that HSV-1-specific CTLs participate in the pathogenesis of corneal stromal disease, these results indicate that i.v. injection of UV HSV-1 at the time of corneal infection may prevent stromal disease by the combined effects of IFN-mediated reduction of the spread of virus in the cornea and inhibition of the activity of the HSV-specific T lymphocytes that induce tissue destruction in the corneal stroma.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-7-1601
1991-07-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/7/JV0720071601.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-7-1601&mimeType=html&fmt=ahah

References

  1. Abghari S. Z., Stulting R. D. 1988; Recovery of herpes simplex virus from ocular tissues of latently infected inbred mice. Investigative Ophthalmology and Visual Science 29:239–243
    [Google Scholar]
  2. Cantell K., Hirvonen S., Kauppinen H.-L., Myllyla G. 1981; Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods in Enzymology 78:29–38
    [Google Scholar]
  3. Centifanto-Fitzgerald Y. M., Yamaguchi T., Kaufmann H. E., Tognon M., Roizman B. 1982; Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. Journal of Experimental Medicine 155:475–489
    [Google Scholar]
  4. Cook S. D., Batra S. K., Brown S. M. 1987; Recovery of herpes simplex virus from the corneas of experimentally infected rabbits. Journal of General Virology 68:2013–2017
    [Google Scholar]
  5. Hendricks R. L., Sugar J. 1984; Lysis of herpes simplex virus-infected targets. II. Nature of the effector cells. Cellular Immunology 83:262–270
    [Google Scholar]
  6. Hendricks R. L., Tumpey T. M. 1990; Contribution of virus and immune factors to herpes simplex virus type 1 induced corneal pathology. Investigative Ophthalmology and Visual Science 31:1929–1939
    [Google Scholar]
  7. Hendricks R. L., Tao M. S. P., Glorioso J. C. 1989a; Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis. Journal of Immunology 142:263–269
    [Google Scholar]
  8. Hendricks R. L., Epstein R. J., Tumpey T. M. 1989b; The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis. Investigative Ophthalmology and Visual Science 30:105–115
    [Google Scholar]
  9. Hill J. M., Shimomura Y., Dudley J. B., Berman E., Haruta Y., Kwon B. S. 1987; Timolol induces HSV-1 ocular shedding in the latently infected rabbit. Investigative Ophthalmology and Visual Science 28:585–590
    [Google Scholar]
  10. Ho D. Y., Mocarski E. S. 1988; β-Galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse. Virology 167:279–283
    [Google Scholar]
  11. Homa F. L., Otal T. M., Glorioso J. C., Levine M. 1986; Transcriptional control signals of a herpes simplex virus type 1 late (γ 2) gene lie within bases – 34 to + 124 relative to the 5′ terminus of the mRNA. Molecular and Cellular Biology 6:3652–3666
    [Google Scholar]
  12. Jameson P., Grossberg S.E. 1981; Virus-yield reduction assay for interferon: picornavirus hemagglutination measurements. Methods in Enzymology 78:357–368
    [Google Scholar]
  13. Ksander B. R., Hendricks R. L. 1987; Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions. Investigative Ophthalmology and Visual Science 28:1986–1993
    [Google Scholar]
  14. Metcalf J. F., Kaufman H.E. 1976; Herpetic stromal keratitis: evidence for cell-mediated immunopathogenesis. American Journal of Ophthalmology 82:827–834
    [Google Scholar]
  15. Metcalf J. F., Hamilton D. S., Reichert R. W. 1979; Herpetic keratitis in athymic (nude) mice. Infection and Immunity 26:1164–1171
    [Google Scholar]
  16. Nash A. A., Ashford N. P. N. 1982; Split T cell tolerance in herpes simplex virus infected mice and its implication for anti-viral immunity. Immunology 45:761–767
    [Google Scholar]
  17. Newell C. K., Martin S., Sendele D., Mercadal C. M., Rouse B. T. 1989; Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. Journal of Virology 63:769–775
    [Google Scholar]
  18. O’Brien W. J., Taylor J. L. 1989; The isolation of herpes simplex virus from rabbit corneas during latency. Investigative Ophthalmology and Visual Science 30:357–364
    [Google Scholar]
  19. Raj N. B. K., Pitha P. M. 1981; Analysis of interferon mRNA in human fibroblast cells induced to produce interferon. Proceedings of the National Academy of Sciences, U.S.A 78:7426–7430
    [Google Scholar]
  20. Reccia R., Del Prete A., Benusiglio E., Orfeo V. 1985; Continuous usage of low doses of human leukocyte interferon with contact lenses in herpetic keratoconjunctivitis. Ophthalmic Research 17:251–256
    [Google Scholar]
  21. Russell R. G., Nasisse M. P., Larsen H. S., Rouse B. T. 1984; Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Investigative Ophthalmology and Visual Science 25:938–944
    [Google Scholar]
  22. Sabbaga E. M. H., Pavan-Langston D., Bean K. M., Dunkel E. C. 1988; Detection of HSV nucleic acid sequences in the cornea during acute and latent ocular disease. Experimental Eye Research 47:545–553
    [Google Scholar]
  23. Spaete R. R., Mocarski E. S. 1985; Regulation of cytomegalovirus gene expression: α and β promoters are trans-activated by viral functions in permissive human fibroblasts. Journal of Virology 56:135–143
    [Google Scholar]
  24. Stewart W. ii, Gosser L., Lockart R. 1971; Priming: a non-antiviral function of interferon. Journal of Virology 7:792–801
    [Google Scholar]
  25. Stulting R. D., Kindle J. C., Nahmias A. J. 1985; Patterns of herpes simplex keratitis in inbred mice. Investigative Ophthalmology and Visual Science 26:1360–1367
    [Google Scholar]
  26. Taylor J. L., O’Brien W. J. 1987; Interferon production in inbred mice during herpetic eye disease. Current Eye Research 6:259–264
    [Google Scholar]
  27. Trousdale M. D., Nesburn A. B. 1984; Human interferon alpha A or alpha D and trifluridine treatment for herpetic keratitis in rabbits. Investigative Ophthalmology and Visual Science 25:480483
    [Google Scholar]
  28. Weber P. C., Levine M., Glorioso J. C. 1987; Rapid identification of non-essential genes of herpes simplex virus type 1 by Tn5 mutagenesis. Science 236:576–579
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-7-1601
Loading
/content/journal/jgv/10.1099/0022-1317-72-7-1601
Loading

Data & Media loading...

Most cited Most Cited RSS feed